Pancreatic Cancer News & Features
Researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.
Study found IRE procedure improved survival for people with stage III disease.
A new set of genes has been identified that can indicate improved survival after surgery for patients with pancreatic cancer. The study also showed that detection of circulating tumor DNA in the blood could provide an early indication of tumor recurrence.
Scientists have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease metastasizes.
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
- New Approach Tackles Hormone Therapy Resistance in Breast Cancer
- MS Pain Management in Patients With Cancer
- Half-Match Donors May be the Perfect Match In Transplantation for Blood Cancers
- Gay, Bisexual Men Report Higher Rates of Skin Cancer Than Heterosexual Men
- Fukushima Radiation May Be Increasing Pediatric Thyroid Cancer Rates
- Targeted Online Advertising May Effectively Deliver Skin Cancer Prevention Education
- DNA Alterations Occur the Earliest in Lung Cancer Development
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|